WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.

Leber, Andrew; Hontecillas, Raquel; Tubau-Juni, Nuria; Lichtiger, Simon; Bassaganya-Riera, Josep

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.

Leber, Andrew; Hontecillas, Raquel; Tubau-Juni, Nuria; Lichtiger, Simon; Bassaganya-Riera, Josep.

Inflamm Bowel Dis ; 28(Supplement_1): S112, 2022 Jan 22.

Article in En | MEDLINE | ID: mdl-35104848

Fulltext

Add to My VHL

Print

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Aspects: Patient_preference Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article